Catalyst Orthopaedics LLC
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Catalyst ranks #45,498 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
- #45,498
- of 49,997 US assignees by volume
- 3rd percentile
- by Innovation Score (14.1/100)
- 4.8
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R45498 · US Corporation #45,498 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #45,498/49,997
- PHOTO-FINISH CAS
- CPC-NARROW A61B · 2 areas
- INNOV-LOW 14.1/100
- CLAIMS-SPARSE 4.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: CAS Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Catalyst’s 14.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Catalyst
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Catalyst Orthopaedics · this assignee 14
Catalyst Orthopaedics · this assignee
14 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Catalyst's Innovation Score is 14.1/100 (3rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Catalyst?
Each dot is one of Catalyst’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Catalyst’s own 4.8 claims/patent is at or below the 10.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Catalyst's grants concentrate
Catalyst Orthopaedics LLC is a focused PatentsView assignee: 2 CPC subclasses with 20% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (3 grants) versus a trough of 2 in 2015. By volume, Catalyst sits between CAS Corporation and Cavius APS.
Who files at Catalyst's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- CAS
CAS Corporation
5 patents
- Case Western Univ…
Case Western University
5 patents
- Castle Island IP…
Castle Island IP Holding LLC
5 patents
- Catalent Pharma S…
Catalent Pharma Solutions, LLC
5 patents
- Caterva
Caterva GMBH
5 patents
- Cava Healthcare
Cava Healthcare Inc.
5 patents
- Cavity Sliders
Cavity Sliders Limited
5 patents
- Cavius APS
Cavius APS
5 patents
- Catalyst Orthopae… ◀
Catalyst Orthopaedics LLC
5 patents
What this shows Catalyst holds 5 patents at rank #45,457, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Catalyst
By rank, the assignees closest to #45,457 in granted patent volume.
- CAS Corporation #45,453 · 5 patents
- Case Western University #45,454 · 5 patents
- Castle Island IP Holding LLC #45,455 · 5 patents
- Catalent Pharma Solutions, LLC #45,456 · 5 patents
- Caterva GMBH #45,458 · 5 patents
- Cava Healthcare Inc. #45,459 · 5 patents
- Cavity Sliders Limited #45,460 · 5 patents
- Cavius APS #45,461 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Catalyst's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Catalyst's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
14 3rd percentile higher than 3% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 40.0% |
| 2016 | 3 | 60.0% |
Which technologies does Catalyst Orthopaedics LLC patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Catalyst Orthopaedics LLC's patent record in context - here's where to go next.
- Catalyst Orthopaedics LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 20% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #45,498 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Catalyst Orthopaedics LLC against CAS Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 14.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.